Case Studies
Green Chemistry for Extractables & Leachables Testing
Discover how Resolian’s green chemistry LC-HRMS method for extractables & leachables testing cut runtime by 37% and solvent use – without compromising sensitivity or quality.
Case Studies
Case Studies
Ultra-Trace NMBA Detection Using HILIC-MS
Learn how Resolian achieved 0.8 ng/mL NMBA detection using HILIC-MS – overcoming reverse-phase limitations for ultra-trace nitrosamine analysis in drug products.
Case Studies
Sustainable SFC-UV Method for Vitamin E Analysis
Discover how Resolian’s platform SFC-UV method analyzes vitamin E across multiple formulations – reducing organic solvent use while meeting GMP requirements.
Case Studies
LC-MS Sensitivity Optimization Using DoE
Discover how Resolian increased LC-MS sensitivity by 438% using Design of Experiments – achieving required detection limits without new equipment investment.
Case Studies
Preventing False Positives in Nitrosamine Testing
False positives in nitrosamine testing can trigger unnecessary product recalls, regulatory scrutiny, and supply chain disruptions—threatening patient access to critical therapies. But what if the contamination isn’t from your product at all?
Blog
Identifying Foreign Matter in Products
What would you do if you found a piece of unidentified material in your toothpaste today? Would you use it? Would you throw the whole tube away? Or, would you send a complaint to the company..?
Foreign matter is an issue across all industries – from food to medicines and consumer products
Case Studies
Flow Cytometry Sample Processing Packages
Whole blood samples for flow cytometry begin degrading within hours of collection, long before most reach a central lab.
For studies measuring protein phosphorylation or receptor occupancy, that instability puts drug mechanism-of-action and binding data at risk.
Resolian’s sample processing package extends stability to 47 days, turning a logistics problem into a controlled, batchable process.
Case Studies
When One Assay Isn’t Enough: Validated Immunogenicity Testing for Antibody-Drug Conjugates
ADC immunogenicity demands more than a standard ADA assay. Resolian’s tiered, domain-specific approach delivers regulatory-ready results across the full method lifecycle.
Case Studies
Development and Validation of an Immunogenicity Assay for Detection of Anti-AAV Antibodies
CASE STUDY – ANTI-AAV ANTIBODIES. We are experienced with a wide range of different proteins and therapeutics…
Case Studies
Challenges of Developing an ADA Assay for Bispecific Antibody Therapeutics and ADA Characterization
Bispecifics (Bs) are biopharmaceutical products that bind to two different targets (epitopes). These are mainly two types: IgG-like (antibodies Abs) and non-IgG-like which include Bites (bispecific T-cell engager) and DARTs (Dual-affinity Re-targeting Antibody)…
